Skip to content

Author

G. Gembillo

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Cardiorenal Syndrome: Pathophysiology, Management, and the Challenge of Therapeutic Inertia

Cardiorenal syndrome describes the clinical consequences of the bidirectional influence that cardiac and renal dysfunction exert on each other—a domain in which single-organ care proves insufficient. A 2024 meta-analysis estimated the pooled prevalence of chronic kidney disease among patients with heart failure at 49%....

G. Gembillo, V. Calabrese, L. Soraci et al. · 0 citations
Review Open access Sep 2026

CAR-T Cell Therapy in Nephrology: Evidence Across Immune-Mediated Kidney Diseases and Plasma Cell Dyscrasias, Renal Toxicity, and Patient Monitoring

In many immune-mediated kidney diseases, tissue injury is driven by dysregulated B-cell immunity, with autoantibodies and complement acting as key effectors at the glomerulus. Corticosteroids and conventional immunosuppressants control these diseases only in part, and they do so at the price of cumulative toxicity and...

L. Visconti, L. Soraci, Lorenzo Lo Cicero et al. · 0 citations
Open access Sep 2026

Diagnostic Accuracy and Alignment With Human Reader Responses Across Five Large Language Models on Complex Clinical Case Challenges

Because a model can outperform clinicians in aggregate yet fail where oversight is least likely to detect it, evaluation of clinical AI should weigh error structure alongside accuracy.

R. Bellocco, L. Soraci, Lorenzo Lo Cicero et al. · 0 citations
Review Jul 2026

Angiotensin system modulation in focal segmental glomerulosclerosis: pharmacological basis and clinical implications

New therapies, including dual AT1/endothelin-A antagonism and podocyte-targeted approaches (apecotrep), show promising proteinuria reductions but have not yet demonstrated clear benefits on hard renal outcomes, while biomarker-driven strategies may enable more tailored treatment, although their clinical impact remains...

G. Gembillo, Chiara Casuscelli, A. La Spada et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.